-->

Jasper Therapeutics Stock Net Income

JSPR Stock  USD 2.90  0.06  2.03%   
Fundamental analysis of Jasper Therapeutics allows traders to better anticipate movements in Jasper Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Last ReportedProjected for Next Year
Net Loss-33.9 M-32.2 M
Net Loss-71.3 M-67.7 M
Net Loss-71.3 M-74.8 M
Net Loss(4.89)(5.13)
Net Income Per E B T 0.98  0.67 
As of 08/01/2025, Net Loss is likely to grow to about (32.2 M). In addition to that, Net Loss is likely to grow to about (67.7 M).
  
Build AI portfolio with Jasper Stock
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Jasper Therapeutics Company Net Income Analysis

Jasper Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Jasper Therapeutics Net Income

    
  (71.27 M)  
Most of Jasper Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jasper Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Jasper Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Jasper Therapeutics is extremely important. It helps to project a fair market value of Jasper Stock properly, considering its historical fundamentals such as Net Income. Since Jasper Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Jasper Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Jasper Therapeutics' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Jasper Therapeutics reported net income of (71.27 Million). This is 120.88% lower than that of the Biotechnology sector and 201.75% lower than that of the Health Care industry. The net income for all United States stocks is 112.48% higher than that of the company.

Jasper Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jasper Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jasper Therapeutics could also be used in its relative valuation, which is a method of valuing Jasper Therapeutics by comparing valuation metrics of similar companies.
Jasper Therapeutics is currently under evaluation in net income category among its peers.

Jasper Therapeutics ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Jasper Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Jasper Therapeutics' managers, analysts, and investors.
Environmental
Governance
Social

Jasper Therapeutics Institutional Holders

Institutional Holdings refers to the ownership stake in Jasper Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Jasper Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Jasper Therapeutics' value.
Shares
Ubs Group Ag2025-03-31
534.6 K
Kingdon Capital Management Llc2025-03-31
490 K
Citadel Advisors Llc2025-03-31
375.2 K
Bank Of America Corp2025-03-31
360.7 K
Geode Capital Management, Llc2025-03-31
263.7 K
Goldman Sachs Group Inc2025-03-31
233.8 K
State Street Corp2025-03-31
227.9 K
Deutsche Bank Ag2025-03-31
169.3 K
Lion Point Capital, Lp2025-03-31
146.5 K
Soleus Capital Management, L.p.2025-03-31
1.5 M
Velan Capital Investment Management Lp2025-03-31
1.4 M

Jasper Fundamentals

About Jasper Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Jasper Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jasper Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jasper Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.